Presently, CAL 18 only warns about grapefruit resulting from its effect on the bioavailability of specific medicines with the selective inhibition of cytochrome P450 3A4 isoenzymes. Although the product or service data (PI) for new medicines which have been substrates for CYP3A4 increasingly mention other fruits (beyond just grapefruit) as interact